ImmuPharma (LON:IMM) Stock Passes Below Two Hundred Day Moving Average of $6.41

ImmuPharma plc (LON:IMMGet Rating)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 6.41 ($0.08) and traded as low as GBX 5.70 ($0.07). ImmuPharma shares last traded at GBX 5.85 ($0.07), with a volume of 511,604 shares.

The company’s 50 day moving average price is GBX 6.21 and its 200 day moving average price is GBX 6.40. The company has a quick ratio of 2.59, a current ratio of 2.68 and a debt-to-equity ratio of 12.36. The firm has a market capitalization of £16.67 million and a price-to-earnings ratio of -1.83.

About ImmuPharma (LON:IMM)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity, metabolism, anti-infectives, and cancer. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

See Also

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.